CP_DEF_BACK-trans.png

HISTORY

 

TBA

OPERATIONS

CP_DOTS.png
 
No avatar.jpeg

Robert Jan Lamers              |    CEO

Robert Jan Lamers, CEO, business development professional with over 15 years of experience in biotech. Former director of the Tech Transfer Office of Amsterdam UMC and University of Amsterdam, former director of AMC Holding, former CEO of Arthrogen and Regenesance, founder of Maxwell Group, Investormatch and Complement Pharma. Current CEO of Orthros Medical.

No avatar.jpeg

Shirley Houps                      |    Operations 

TBA

DEVELOPMENT TEAM

 
Glossy_Brightlands_Divers_230221_0123.jpg

Tim Welting, PhD       | Co-founder, focus peptide development

Tim Welting is professor at the department of orthopedic surgery of MUMC+ and an expert in molecular cartilage biology. He is head of the Laboratory for Experimental Orthopedics and is principal investigator and group leader of the Molecular Cartilage Biology research group. He received his PhD in biochemistry from the Radboud University Nijmegen in 2007.

Glossy_Brightlands_Divers_230221_0105.jpg

Pieter Emans, PhD MD       | Co-founder, focus application

Pieter Emans is orthopaedic surgeon at MUMC+ and specialized in arthroscopic surgery and prosthetics of the knee and shoulder since 2010. He finished his PhD in 2007 focused on Cartilage biology, exploring the possibility to generate cartilage at an ectopical site and repair cartilage defects with this approach.  This work received the Goran Bauer grant of the Nordic Orthopaedic Federation (NOF) and a long lasting grant (LLP 14) of the Dutch Arthritis Society (Reumafonds). After completing his medical specialization, he did a Lars Peterson fellowship in knee surgery and cartilage recovery in the US (Boston, Chicago, San Diego and LA). 

Glossy_Brightlands_Divers_230221_0047.jpg

Lodewijk van Rhijn, PhD MD | Co-founder, focus strategic development

Lodewijk van Rhijn is professor of orthopedic surgery at MUMC+. He is chair of the department of orthopedic surgery and heading clinical operations and research strategy. He is chairman of the multidisciplinary translational research Maastricht Movement Centre. He received his MD title in 1990, holds a PhD in medicine from Maastricht University and was appointed as professor in orthopedic biotechnology in 2008.

SUPERVISORY BOARD

 
image001.jpg

Lodewijk Ridderbos                      

No avatar.jpeg

Joost Holthuis                     

Partners